Opportunity Information: Apply for W81XWH 09 OCRP IDA
Apply for W81XWH 09 OCRP IDA
- The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DOD Ovarian Cancer Idea Development Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
- This funding opportunity was created on Jan 20, 2009 and posted on Jan 20, 2009.
- Applicants must submit their applications by Jun 2, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $8,400,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 14 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The DOD Ovarian Cancer Idea Development Award (FY09) is a Department of the Army/U.S. Army Medical Research Acquisition Activity (USAMRAA) funding opportunity under the Ovarian Cancer Research Program (OCRP) designed to support high-impact, innovative ovarian cancer research. The intent of the award is to back ideas that can push the field forward rather than incremental work, and it is structured as a research and development award within the Science and Technology category. Historically, this mechanism was run in FY02 through FY06 and again in FY08, attracting substantial interest across the research community; across those years, 681 applications were submitted and 58 awards were made, which signals both strong competition and a selective emphasis on projects with clear potential to change understanding or practice.
For FY09, the program remained open to proposals across the full spectrum of ovarian cancer research, but it explicitly highlighted several priority needs where the community was seen as needing progress. The first priority area focused on how ovarian cancer begins, including initiation events and precursor lesions, with a particular emphasis on the role of the fallopian tube in disease pathogenesis. The second area emphasized improving the molecular understanding of ovarian cancer heterogeneity, reflecting the reality that ovarian cancer is not a single uniform disease and that differences between subtypes can drive outcomes and treatment response. The third priority centered on the validation of biomarkers, especially those that could improve diagnosis, enable molecular imaging approaches, or predict and track therapeutic response, all of which are key bottlenecks in earlier detection and more personalized treatment strategies.
Administratively, the opportunity was posted on January 20, 2009, with an application deadline of June 2, 2009, and an archive date of July 2, 2009. The total estimated funding available was $8.4 million, with an expectation of about 14 awards. The funding instrument type was listed as both a cooperative agreement and a grant, indicating that supported projects might range from more independently executed studies to efforts involving more active programmatic involvement typical of cooperative agreements, depending on the specific award terms. There was no cost-sharing or matching requirement, which reduces barriers for applicants who may not have institutional matching funds available.
Eligibility was described as unrestricted, meaning the competition was broadly open to a wide range of applicant organizations, subject to any additional eligibility clarifications that might appear in the full announcement. The CFDA number associated with the program was 12.420 (Military Medical Research and Development), situating it within the DOD medical research portfolio. For applicants needing assistance, the announcement provided contact points for access issues and submission support, including PA HELP and the CDMRP eReceipt/Helpdesk contacts.
Frequently Asked Questions (FAQs)
What is the DOD Ovarian Cancer Idea Development Award (FY09)?
The DOD Ovarian Cancer Idea Development Award (FY09) is a funding opportunity offered through the Department of the Army/U.S. Army Medical Research Acquisition Activity (USAMRAA) under the Ovarian Cancer Research Program (OCRP). It is designed to support high-impact, innovative ovarian cancer research, with an emphasis on ideas that could push the field forward rather than incremental advances.
What is the main goal of this award mechanism?
The stated intent is to fund research ideas with clear potential to change understanding or practice in ovarian cancer. The mechanism is positioned to support innovative, field-advancing concepts rather than projects that primarily extend existing work in small steps.
What type of award is this considered (program category)?
This opportunity is structured as a research and development award within the Science and Technology category.
Who is offering and administering this opportunity?
The opportunity is associated with the Department of Defense and is administered through the Department of the Army/U.S. Army Medical Research Acquisition Activity (USAMRAA) as part of the Ovarian Cancer Research Program (OCRP).
What research areas are eligible to apply?
For FY09, proposals were open to the full spectrum of ovarian cancer research. In addition, the announcement highlighted specific priority needs where progress was particularly desired.
What priority research areas were highlighted for FY09?
The FY09 announcement explicitly highlighted three priority areas:
- Ovarian cancer initiation and precursor lesions, including initiation events and precursor lesions, with particular emphasis on the role of the fallopian tube in disease pathogenesis.
- Molecular understanding of ovarian cancer heterogeneity, reflecting the need to better understand differences among ovarian cancer subtypes and how those differences affect outcomes and treatment response.
- Biomarker validation, especially biomarkers that could improve diagnosis, enable molecular imaging, or predict and track therapeutic response.
Is this opportunity limited only to the highlighted priority areas?
No. Based on the information provided, the program remained open to proposals across the full spectrum of ovarian cancer research, while also emphasizing the priority needs listed in the announcement.
What is the estimated total funding available for FY09?
The total estimated funding available for FY09 was $8.4 million.
How many awards were expected to be made?
The program expected to make about 14 awards.
How competitive is this award?
Historically, this mechanism attracted substantial interest and was selective. Across FY02 through FY06 and again in FY08, 681 applications were submitted and 58 awards were made. This history suggests strong competition and an emphasis on proposals with clear potential for high impact.
When was the opportunity posted?
The opportunity was posted on January 20, 2009.
What was the application deadline?
The application deadline was June 2, 2009.
What is the archive date listed for the opportunity?
The archive date was July 2, 2009.
What funding instrument types were listed?
The funding instrument type was listed as both a cooperative agreement and a grant. This indicates that, depending on the specific award terms, supported projects could range from more independently executed studies (typical of grants) to efforts with more active programmatic involvement (typical of cooperative agreements).
Is cost-sharing or matching required?
No. The opportunity stated there was no cost-sharing or matching requirement.
Who is eligible to apply?
Eligibility was described as unrestricted, meaning the competition was broadly open to a wide range of applicant organizations, subject to any additional eligibility clarifications that might be included in the full announcement.
What is the CFDA number for this opportunity?
The CFDA number associated with this program is 12.420 (Military Medical Research and Development).
What program is this opportunity associated with?
This opportunity is part of the Ovarian Cancer Research Program (OCRP) within the Department of Defense medical research portfolio.
What kind of projects does the program want to support?
Based on the description provided, the program is looking for high-impact, innovative research concepts in ovarian cancer, especially those that can address major gaps such as understanding disease initiation (including the fallopian tube role), clarifying molecular heterogeneity, and validating biomarkers for diagnosis, imaging, and therapy response monitoring.
Where can applicants get help with access or submission issues?
The announcement provided contacts for access issues and submission support, including PA HELP and the CDMRP eReceipt/Helpdesk contacts.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: DOD Neurofibromatosis Investigator Initiated Research Award
Previous opportunity: State Justice Statistics Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 09 OCRP IDA
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 09 OCRP IDA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DOD Neurofibromatosis Investigator Initiated Research Award Apply for W81XWH 09 NFRP IIRA Funding Number: W81XWH 09 NFRP IIRA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DOD Neurofibromatosis Clinical Trial Award Apply for W81XWH 09 NFRP CTA Funding Number: W81XWH 09 NFRP CTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DOD Tuberous Sclerosis Complex Idea Development Award Apply for W81XWH 09 TSCRP IDA Funding Number: W81XWH 09 TSCRP IDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DOD Tuberous Sclerosis Complex Clinical and Translational Research Award Apply for W81XWH 09 TSCRP CTRA Funding Number: W81XWH 09 TSCRP CTRA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DOD Breast Cancer Predoctoral Traineeship Award Apply for W81XWH 09 BCRP PREDOC Funding Number: W81XWH 09 BCRP PREDOC Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DOD Breast Cancer Postdoctoral Fellowship Award Apply for W81XWH 09 BCRP POSTDOC Funding Number: W81XWH 09 BCRP POSTDOC Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| IPTO Office Apply for DARPA BAA 08 34 PDF Funding Number: DARPA BAA 08 34 PDF Agency: DARPA Information Processing Technology Office Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Rio Grande silvery minnow PVA Model Single Source Continuation Apply for NMFWS012109 Funding Number: NMFWS012109 Agency: Fish and Wildlife Service Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Basic Research in Rotorcraft Technology Apply for ONRBAA09 007 Funding Number: ONRBAA09 007 Agency: Office of Naval Research Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DOD Ovarian Cancer Collaborative Translational Research Award Apply for W81XWH 09 OCRP CTR Funding Number: W81XWH 09 OCRP CTR Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| FY09 DOD Prostate Cancer Idea Development Award Apply for W81XWH 09 PCRP IDA Funding Number: W81XWH 09 PCRP IDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| FY09 DOD Prostate Cancer Synergistic Idea Development Award Apply for W81XWH 09 PCRP SIDA Funding Number: W81XWH 09 PCRP SIDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Breast Cancer Impact Award Apply for W81XWH 09 BCRP IMPT Funding Number: W81XWH 09 BCRP IMPT Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Breast Cancer Multi Team Award Apply for W81XWH 09 BCRP MTA Funding Number: W81XWH 09 BCRP MTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Network Science Collaborative Technology Alliance (NS CTA) Apply for W911NF 08 R 0013 Funding Number: W911NF 08 R 0013 Agency: Dept of the Army Materiel Command Category: Science and Technology and other Research and Development Funding Amount: $252,000,000 |
| Course, Curriculum, and Laboratory Improvement Apply for 09 529 Funding Number: 09 529 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $5,000,000 |
| DoD Peer Reviewed Medical Research Program Technology/Therapeutic Development Award Apply for W81XWH 09 PRMRP TTDA Funding Number: W81XWH 09 PRMRP TTDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Peer Reviewed Medical Research Program Clinical Trial Award Apply for W81XWH 09 PRMRP CTA Funding Number: W81XWH 09 PRMRP CTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Long Range Broad Agency Announcement (BAA) for Navy and Marine Corp Science and Technology Apply for ONRBAA09 001 Funding Number: ONRBAA09 001 Agency: Office of Naval Research Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cooperative Ecosystem Studies Unit, Great Lakes Northern Forest CESU Apply for 09HQPA0019 Funding Number: 09HQPA0019 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 09 OCRP IDA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.